Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.1608 per ML under NDC 51672422708. Its NADAC has been published 244 times since Oct 27, 2021.
Strength
2.5 mg/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672422708
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA210978On Market Since
6/30/2021
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 244 times since Oct 27, 2021, and over the history we have for it it has declined 64.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1608 per ML |
|---|---|
| All-time high | $0.6119 (Dec 15, 2021) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.2318 |
| Average price | $0.2782 |
| Largest weekly change | +35.6% (Nov 17, 2021) |
| Weeks tracked | 244 |
| Tracking since | Oct 27, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.1608 per ML (NDC 51672422708), effective Jun 24, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 64.4%. It has been tracked across 244 weekly CMS publications since Oct 27, 2021.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Oct 27, 2021, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $0.6119 (Dec 15, 2021), with a median of $0.2318 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CLOBAZAM 2.5 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 51672422708) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification